Reference number : 172-2025-2026-Q1-1031097, amendment number : , agreement type : C, recipient legal name : RS Therapeutics Inc., recipient country : CA, recipient province : AB, recipient city : Edmonton|Edmonton, recipient postal code : T6R 0L1, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Commercialization Strategy for Marketing Finished Product, agreement title french : Stratégie de commercialisation du produit fini, agreement number : 1031097, agreement value : 24900.0, agreement start date : 2025-06-01, agreement end date : 2025-11-03, description english : The project will prepare a portfolio for commercialization of the product to launch to market., description french : Le projet permettra de préparer un portefeuille en vue de la commercialisation du produit sur le marché., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada